A Study to Evaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or Secondarily Generalized Tonic-clonic Seizures
NCT04202159
·
clinicaltrials.gov ↗
COMPLETED
Status
187
Enrollment
INDUSTRY
Sponsor class
Conditions
Seizures
Interventions
DRUG:
Perampanel
DRUG:
Perampanel
Sponsor
Eisai GmbH